Liquidia Technologies Inc(LQDA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

LQDA Liquidia Technologies Inc

盘前交易 11-05 05:20:54 EST

10.46

-0.52

-4.74%

最高10.96	最低10.45	成交量89.66万
今开10.95	昨收10.98	日振幅4.69%
总市值8.83亿	流通市值5.69亿	总股本8,438万
成交额950.30万	换手率1.65%	流通股本5,441万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"LQDA","market":"US","secType":"STK","nameCN":"Liquidia Technologies Inc","latestPrice":10.46,"timestamp":1730754000000,"preClose":10.98,"halted":0,"volume":896577,"delay":0,"floatShares":54406700,"shares":84377963,"eps":-1.590181,"marketStatus":"盘前交易","marketStatusCode":1,"change":-0.52,"latestTime":"11-05 05:20:54 EST","open":10.95,"high":10.96,"low":10.445,"amount":9503007.007593,"amplitude":0.046903,"askPrice":11.78,"askSize":100,"bidPrice":9.42,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-1.590181,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1730817000000},"adr":0,"listingDate":1532577600000,"adjPreClose":10.46,"adrRate":0,"postHourTrading":{"tag":"盘后","latestPrice":10.51,"preClose":10.46,"latestTime":"18:32 EST","volume":23379,"amount":244544.5,"timestamp":1730763144398},"volumeRatio":1.473929228878756,"impliedVol":0.6583,"impliedVolPercentile":0.1355},"requestUrl":"/m/hq/s/LQDA","defaultTab":"news","newsList":[{"id":"2473105068","title":"Liquidia Corporation盘中异动 大幅拉升5.08%报10.54美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2473105068","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473105068?lang=zh_cn&edition=full","pubTime":"2024-10-07 21:37","pubTimestamp":1728308258,"startTime":"0","endTime":"0","summary":"北京时间2024年10月07日21时37分，Liquidia Corporation股票出现异动，股价大幅上涨5.08%。截至发稿，该股报10.54美元/股，成交量15.8867万股，换手率0.19%，振幅4.69%。Liquidia Corporation股票所在的生物技术行业中，整体涨幅为0.15%。Liquidia Corporation公司简介：Liquidia Corp 是一家总部位于美国的生物制药公司，专注于开发、制造和商业化产品，以满足未满足的患者需求，目前的重点是肺动脉高压  和与间质性肺病相关的肺动脉高压的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410072137399719ea1b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410072137399719ea1b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4161","LQDA","LU0417517546.SGD","LU1989772840.SGD","LU0211331839.USD","LU0208291251.USD","LU0320765489.SGD","BK4588","LU0256863811.USD","LU0256863902.USD","PH","LU0070302665.USD","LU1989772923.USD","BK4580","BK4007","BK4585"],"gpt_icon":0},{"id":"2468504617","title":"Liquidia Corporation盘中异动 早盘股价大涨5.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2468504617","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468504617?lang=zh_cn&edition=full","pubTime":"2024-09-19 23:26","pubTimestamp":1726759573,"startTime":"0","endTime":"0","summary":"北京时间2024年09月19日23时26分，Liquidia Corporation股票出现异动，股价大幅上涨5.25%。Liquidia Corporation股票所在的生物技术行业中，整体涨幅为1.75%。Liquidia Corporation公司简介：Liquidia Corp 是一家总部位于美国的生物制药公司，专注于开发、制造和商业化产品，以满足未满足的患者需求，目前的重点是肺动脉高压  和与间质性肺病相关的肺动脉高压的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240919232614a1db3625&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240919232614a1db3625&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0256863902.USD","BK4007","BK4588","LQDA","LU0417517546.SGD","LU0256863811.USD","LU1989772923.USD","LU0320765489.SGD","LU0070302665.USD","LU0208291251.USD","BK4161","LU1989772840.SGD","BK4580","PH","LU0211331839.USD","BK4585"],"gpt_icon":0},{"id":"2461549381","title":"Liquidia Corporation盘中异动 大幅上涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2461549381","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461549381?lang=zh_cn&edition=full","pubTime":"2024-08-24 02:16","pubTimestamp":1724437018,"startTime":"0","endTime":"0","summary":"北京时间2024年08月24日02时16分，Liquidia Corporation股票出现波动，股价大幅上涨5.00%。Liquidia Corporation股票所在的生物技术行业中，整体涨幅为0.20%。Liquidia Corporation公司简介：Liquidia Corp 是一家总部位于美国的生物制药公司，专注于开发、制造和商业化产品，以满足未满足的患者需求，目前的重点是肺动脉高压  和与间质性肺病相关的肺动脉高压的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240824021659a1d608bf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240824021659a1d608bf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4161","BK4007","LU0256863902.USD","LU0208291251.USD","LU0320765489.SGD","LU0256863811.USD","BK4588","LU1989772923.USD","LU0417517546.SGD","LU0070302665.USD","LU1989772840.SGD","BK4585","LU0211331839.USD","PH","BK4580","LQDA"],"gpt_icon":0},{"id":"2461434815","title":"BUZZ-Liquidia挑战竞争对手吸入式药物的监管排他性后业绩下滑","url":"https://stock-news.laohu8.com/highlight/detail?id=2461434815","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461434815?lang=zh_cn&edition=full","pubTime":"2024-08-22 21:56","pubTimestamp":1724335011,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 )) (更新)    8月22日 - ** Liquidia Corp   股价下跌2.61%，报9.72美元** 该公司称已向美国哥伦比亚特区地方法院提起 (link) 诉讼，对美国食品和药物管理局授予United Therapeutics    竞争对手药物Tyvaso DPI 3年独家经营权的决定提出质疑。** 卫生监管机构周一推迟了对Liquidia公司吸入式药物yutrepia的 (link) 传统批准，只允许暂时批准。** 目前，该药物的最终批准将推迟到 2025 年 5 月 23 日专营权到期之后。** 股价今年以来下跌了约 18","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LQDA","BUZZ","BK4532","LU1699723380.USD","BK4139","LU1571399168.USD","UTHR","BK4007"],"gpt_icon":0},{"id":"2461313416","title":"BUZZ--美国股票走势-Wolfspeed、Synopsys、Zuora","url":"https://stock-news.laohu8.com/highlight/detail?id=2461313416","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461313416?lang=zh_cn&edition=full","pubTime":"2024-08-22 19:50","pubTimestamp":1724327451,"startTime":"0","endTime":"0","summary":"标普500指数小型股  上涨0.22%，报5,653.75点；纳斯达克100指数小型股  上涨0.34%，报19,977点。** Liquidia Corp   ：盘前下跌0.9%BUZZ - 在该公司质疑竞争对手吸入式药物的监管专属性后下跌   ** Synopsys Inc   ：盘前上涨 2.4%BUZZ - 因乐观的第四季度预测和第三季度业绩而上涨   ** Cyclo Therapeutics Inc   ：盘前下跌16.7%BUZZ - 与Rafael Holdings达成合并协议后下跌","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4551","BK4558","LU1815333072.USD","LU1923623000.USD","LU1989764664.SGD","BUZZ","LU2404859667.USD","SCHW","LU2433249047.HKD","LU0690374961.EUR","LU1791807156.HKD","LU0106831901.USD","URBN","LU0345774391.USD","LU2125909593.SGD","LU1989764748.USD","LU0082616367.USD","LU0345774631.USD","LU1988902786.USD","BK4097","LU2125909247.SGD","BK4116","SG9999014013.SGD","LU0130517989.USD","BK4528","LU0130102774.USD","LU0648001328.SGD","AAP","BK4559","LU2404859741.USD","SNPS","LU0266013472.USD","LU1951200564.SGD","ZM","LU0690374615.EUR","LU1951198990.SGD","LU0061474960.USD","SG9999014039.USD","BK4007","SG9999014005.SGD","CYTH","LQDA","LU0889565833.HKD","BK4535","ZUO","SGXZ23171101.USD","BK4094","BK4585"],"gpt_icon":1},{"id":"2461243394","title":"BUZZ-Liquidia因竞争对手的吸入式药物在监管部门的独家经营权受到挑战而下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2461243394","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461243394?lang=zh_cn&edition=full","pubTime":"2024-08-22 18:41","pubTimestamp":1724323292,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    8月22日 - ** Liquidia公司  股价盘前下跌2.71%，报9.71美元** 该公司称已向美国哥伦比亚特区地方法院提起 (link) 诉讼，质疑FDA授予United Therapeutics    竞争对手药物Tyvaso DPI 3年独家经营权的决定。** 卫生监管机构周一推迟了对Liquidia公司吸入式药物yutrepia的 (link) 传统批准，只允许暂时批准。** 目前，该药的最终批准将推迟到 2025 年 5 月 23 日专营权到期之后。** 截至上一交易日收盘，股价年累计下跌约 17","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LU1571399168.USD","BK4532","LU1699723380.USD","BK4007","UTHR","BUZZ","LQDA"],"gpt_icon":0},{"id":"2461391527","title":"更新版 1-Liquidia挑战竞争对手吸入式药物的监管排他性","url":"https://stock-news.laohu8.com/highlight/detail?id=2461391527","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461391527?lang=zh_cn&edition=full","pubTime":"2024-08-22 18:22","pubTimestamp":1724322157,"startTime":"0","endTime":"0","summary":"     路透8月22日 - Liquidia Corp   周四表示，它已对美国食品和药物管理局授予United Therapeutics   治疗肺部疾病的吸入式药物三年专营权的决定提出法律挑战。美国食品和药物管理局周一批准了United Therapeutics公司的Tyvaso DPI的监管专营权，从而推迟了Liquidia公司的吸入式药物yutrepia的传统批准时间。Liquidia 向哥伦比亚特区地方法院提起诉讼。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LQDA","BK4532","UTHR","LU1571399168.USD","LU1699723380.USD","BK4139","BK4007"],"gpt_icon":0},{"id":"2461993383","title":"Liquidia 提起诉讼，质疑竞争对手吸入式药物的监管排他性","url":"https://stock-news.laohu8.com/highlight/detail?id=2461993383","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461993383?lang=zh_cn&edition=full","pubTime":"2024-08-22 18:06","pubTimestamp":1724321205,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    路透8月22日 - Liquidia Corp   周四表示，该公司已向美国哥伦比亚特区地方法院提起诉讼，对美国食品和药物管理局最近决定授予United Therapeutics的  治疗一种肺部疾病的吸入式药物三年独家经营权一事提出质疑。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["UTHR","LU1699723380.USD","BK4139","BK4007","LQDA","LU1571399168.USD","BK4532"],"gpt_icon":0},{"id":"2461870011","title":"Liquidia Corporation盘中异动 股价大涨5.00%报10.08美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2461870011","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461870011?lang=zh_cn&edition=full","pubTime":"2024-08-22 03:43","pubTimestamp":1724269392,"startTime":"0","endTime":"0","summary":"北京时间2024年08月22日03时43分，Liquidia Corporation股票出现异动，股价急速拉升5.00%。截至发稿，该股报10.08美元/股，成交量208.558万股，换手率2.72%，振幅7.60%。Liquidia Corporation股票所在的生物技术行业中，整体跌幅为0.43%。Liquidia Corporation公司简介：Liquidia Corp 是一家总部位于美国的生物制药公司，专注于开发、制造和商业化产品，以满足未满足的患者需求，目前的重点是肺动脉高压  和与间质性肺病相关的肺动脉高压的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240822034313ab5ee379&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240822034313ab5ee379&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0417517546.SGD","PH","LU0211331839.USD","BK4007","LU0070302665.USD","BK4580","LU0208291251.USD","LU0320765489.SGD","LU1989772923.USD","LQDA","BK4585","LU0256863811.USD","LU0256863902.USD","BK4161","BK4588","LU1989772840.SGD"],"gpt_icon":0},{"id":"2460040720","title":"美国研究综述-Alight、万事达卡、Visa","url":"https://stock-news.laohu8.com/highlight/detail?id=2460040720","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460040720?lang=zh_cn&edition=full","pubTime":"2024-08-20 15:19","pubTimestamp":1724138381,"startTime":"0","endTime":"0","summary":"    路透8月20日 - 华尔街证券分析师周二调整了对包括 Alight、Mastercard 和 Visa 在内的几家美国上市公司的评级和目标价。要闻             * Alight Inc   ：摩根大通将其评级从 \"增持 \"下调至 \"中性\"。* 万事达卡  ：摩根大通将目标价从500美元上调至570美元             * Visa Inc   ：摩根大通将目标价从290美元上调至320美元 以下是路透周二报道的美国公司研究行动摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AUNA","BILL","BFH","LU0545562505.USD","MA","CUZ","LQDA","EAT","PUBM","FLNT","LINE","AVDX","LU1559883803.SGD","LU0053666078.USD","RELY","V","DOCS","CON","LU0106831901.USD","OBDC","ALIT","GPN","LC","NNN","CPAY","LU","PAYX","CAVA","CMPO","LU0426417589.USD","FLYW","NTRA","BK4097","BR","LU1815336091.USD","FOA","LU0130102774.USD","HPP","FIS","O","ADP","FI","LU0566484027.USD","KEY","PAY"],"gpt_icon":1},{"id":"2460105931","title":"BUZZ--美国股票走势-传承、J.B. Hunt、麦当劳","url":"https://stock-news.laohu8.com/highlight/detail?id=2460105931","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460105931?lang=zh_cn&edition=full","pubTime":"2024-08-20 00:06","pubTimestamp":1724083580,"startTime":"0","endTime":"0","summary":"        *      个股异动的 Eikon 搜索字符串：[STXBZ］        *      The Day Ahead 新闻通讯：          *      The Morning News Call时事通讯：      8月19日 - 华尔街主要股指在创下今年最佳一周表现后，在周一波澜不惊的交易中延续涨势，而投资者则期待美联储主席鲍威尔在杰克森霍尔发表讲话，寻找降息迹象。美东时间11:39 ，道琼斯工业平均指数  上涨0.48%，报40,855.02 点。标普500指数  上涨0.42%，报5577.76点；纳斯达克综合指数  上涨0.40%，报17702.387点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SHAK","LU1223083913.SGD","DDM","LU1223082196.USD","IE00BJTD4N35.SGD","BK4504","LINE","SDOW","SQQQ","LU2264538146.SGD","BK4210","LU0690374615.EUR","MOS","BUZZ","MNQmain","MCD","NKLA","HL","TQQQ","BK4183",".IXIC","LQDA","PSQ","NEM","JBHT",".DJI",".SPX","IE00B19Z4B17.USD","DXD","LU2404859667.USD","LU0889565833.HKD","LU1989764664.SGD","QLD","LU0256863811.USD","UDOW","DJX","BROS","LU0690374961.EUR","SOND","DOG","KA","HPQ","NQmain","QID"],"gpt_icon":1},{"id":"2460034495","title":"Liquidia Corporation股价重挫34.37% 市值跌2.44亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2460034495","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460034495?lang=zh_cn&edition=full","pubTime":"2024-08-19 21:31","pubTimestamp":1724074305,"startTime":"0","endTime":"0","summary":"北京时间2024年08月19日21时31分，Liquidia Corporation股票出现异动，股价急速跳水34.37%。Liquidia Corporation股票所在的生物技术行业中，整体涨幅为0.00%。Liquidia Corporation公司简介：Liquidia Corp 是一家总部位于美国的生物制药公司，专注于开发、制造和商业化产品，以满足未满足的患者需求，目前的重点是肺动脉高压  和与间质性肺病相关的肺动脉高压的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408192131459f3a0c26&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408192131459f3a0c26&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1989772923.USD","BK4588","ALZN","LU0256863902.USD","BK4539","BK4580","LU0256863811.USD","LU0208291251.USD","BK4161","LU0211331839.USD","LU0417517546.SGD","BK4007","LQDA","LU0320765489.SGD","LU0070302665.USD","LU1989772840.SGD","BK4139","PH","BK4585"],"gpt_icon":0},{"id":"2460003883","title":"BUZZ--美国股票走势-先进微器件、Liquidia、Xperi","url":"https://stock-news.laohu8.com/highlight/detail?id=2460003883","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460003883?lang=zh_cn&edition=full","pubTime":"2024-08-19 19:58","pubTimestamp":1724068723,"startTime":"0","endTime":"0","summary":"        *      Eikon 个股走势搜索字符串：[STXBZ］        *      The Day Ahead 新闻通讯：          *      The Morning News Call 新闻通讯：      8月19日 - 周一，美国股指期货变化不大，此前华尔街创下了今年以来最好的一周，投资者期待美联储主席鲍威尔在杰克森霍尔发表讲话，寻找降息迹象。标普500指数小型股  上涨0.03%，报5,580点；纳斯达克100指数小型股  上涨0.01%，报19,608.25点。** B. Riley Financial Inc   ：盘前下跌 13.0%BUZZ - 股价下跌 9%，延续上周的抛售势头   ** Sonder Holdings Inc   ：盘前上涨 16.8%BUZZ - 与万豪酒店达成许可协议后股价上涨","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4566","BK4529","IE0031619046.USD","XPER","BK4534","IE0009356076.USD","BK4512","LU0823434583.USD","LU0889565833.HKD","LU1242518931.SGD","LU1316542783.SGD","LU1880398471.USD","IE00BMPRXN33.USD","LU0823421416.USD","AMD","LU2264538146.SGD","LU1988902786.USD","BK4588","BK4575","BUZZ","IE00B7SZL793.SGD","BK4554","BK4524","LU1242518857.USD","LU1923623000.USD","BK4209","SOND","BK4583","LQDA","LU2458330243.SGD","BK4077","LU1803068979.SGD","LU0081259029.USD","IE0004445239.USD","IE00B5949003.HKD","LU0979878070.USD","LU1303367103.USD","LU0082616367.USD","SHAK","BROS","BK4097","LU2098885051.SGD","LU0823421333.USD","LU0056508442.USD","LU1951200564.SGD","LU1880398554.USD","LU2360106780.USD"],"gpt_icon":1},{"id":"2460897540","title":"BUZZ-Liquidia 因美国 FDA 暂缓最终批准降压药而暴跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2460897540","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460897540?lang=zh_cn&edition=full","pubTime":"2024-08-19 18:34","pubTimestamp":1724063681,"startTime":"0","endTime":"0","summary":"    8月19日 - ** Liquidia公司  股价盘前下跌36%至9.03美元 ** 美国 FDA 暂时批准  公司的吸入式降压药 Yutrepia，但未获传统批准** 暂定批准表明 Yutrepia 符合批准所需的所有质量、安全性和有效性监管标准，但必须等待竞争产品的监管专属期到期后才能获得最终批准 - LQDA** 该公司称，Yutrepia的最终批准可能要等到2025年5月23日United Therapeutics公司的   Tyvaso的监管专营权到期之后。** LQDA称将对FDA授予UTHR的Tyvaso独家监管权的决定提出质疑 ** 截至上次收盘，LQDA年累计上涨17.3%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BUZZ","BK4007","LQDA"],"gpt_icon":0},{"id":"2460008639","title":"美国食品和药物管理局初步批准Liquidia公司的吸入式降压药","url":"https://stock-news.laohu8.com/highlight/detail?id=2460008639","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460008639?lang=zh_cn&edition=full","pubTime":"2024-08-19 18:05","pubTimestamp":1724061941,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    路透8月19日 - Liquidia公司周一表示，美国食品和药物管理局已初步批准该公司的  药物用于治疗肺部高血压和一种肺部疾病患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LQDA","BK4007"],"gpt_icon":0},{"id":"2460624921","title":"Liquidia Corporation2024财年第二财季实现净利润-27.94百万美元，同比减少18.79%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460624921","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460624921?lang=zh_cn&edition=full","pubTime":"2024-08-17 00:00","pubTimestamp":1723824031,"startTime":"0","endTime":"0","summary":"8月17日，Liquidia Corporation公布财报，公告显示公司2024财年第二财季净利润为-27.94百万美元，同比减少18.79%；其中营业收入为3.66百万美元，同比减少23.59%，每股基本收益为-0.37美元。从资产负债表来看，Liquidia Corporation总负债1.15亿美元，其中短期债务1.23百万美元，资产负债比为1.54，流动比率为0.07。机构评级：截至2024年8月17日，当前有6家机构对Liquidia Corporation目标价做出预测，其中目标均价为27.00美元，其中最低目标价为22.00美元，最高目标价为32.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408170004589f31affd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408170004589f31affd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LQDA"],"gpt_icon":0},{"id":"2459186271","title":"Liquidia Corporation盘中异动 临近午盘快速上涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459186271","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459186271?lang=zh_cn&edition=full","pubTime":"2024-08-14 00:00","pubTimestamp":1723564820,"startTime":"0","endTime":"0","summary":"北京时间2024年08月14日00时00分，Liquidia Corporation股票出现波动，股价快速上涨5.00%。Liquidia Corporation股票所在的生物技术行业中，整体涨幅为1.78%。Liquidia Corporation公司简介：Liquidia Corp 是一家总部位于美国的生物制药公司，专注于开发、制造和商业化产品，以满足未满足的患者需求，目前的重点是肺动脉高压  和与间质性肺病相关的肺动脉高压的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240814000021af97442c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240814000021af97442c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0211331839.USD","LU1989772923.USD","LU0208291251.USD","LQDA","LU1989772840.SGD","BK4585","BK4161","PH","BK4580","BK4007","LU0070302665.USD","LU0320765489.SGD","BK4588"],"gpt_icon":0},{"id":"2459959497","title":"Liquidia Corporation盘中异动 临近收盘大幅拉升5.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459959497","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459959497?lang=zh_cn&edition=full","pubTime":"2024-08-13 04:00","pubTimestamp":1723492859,"startTime":"0","endTime":"0","summary":"北京时间2024年08月13日04时00分，Liquidia Corporation股票出现异动，股价大幅上涨5.22%。Liquidia Corporation股票所在的生物技术行业中，整体跌幅为1.42%。Liquidia Corporation公司简介：Liquidia Corp 是一家总部位于美国的生物制药公司，专注于开发、制造和商业化产品，以满足未满足的患者需求，目前的重点是肺动脉高压  和与间质性肺病相关的肺动脉高压的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240813040059aefe7049&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240813040059aefe7049&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4585","LU0070302665.USD","LU0320765489.SGD","LU0211331839.USD","LU1989772923.USD","LU0208291251.USD","LQDA","BK4588","LU1989772840.SGD","PH","BK4580","BK4161"],"gpt_icon":0},{"id":"1119866519","title":"异动解读 | Liquidia Technologies Inc股价大涨5.06% 或受行业向好及长期前景预期影响","url":"https://stock-news.laohu8.com/highlight/detail?id=1119866519","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1119866519?lang=zh_cn&edition=full","pubTime":"2024-08-09 16:07","pubTimestamp":1723190826,"startTime":"0","endTime":"0","summary":"Liquidia Technologies Inc今日盘中股价大涨5.06%,报收于11.22美元/股。该公司是一家专注于开发、制造和商业化生物制药产品的公司,主要致力于治疗肺动脉高压等疾病。首先,公司所在的生物技术行业当天整体上涨1.1%,行业向好带动了该股上涨。其次,公司利用自主研发的PRINT技术进行新药研发,市场对其长期前景抱有期望。不过,由于缺乏直接相关新闻报道,无法完全确定导致该股大涨的具体原因。Liquidia股价能否持续上涨,还需进一步观察公司的基本面表现和市场反应。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LQDA"],"gpt_icon":0},{"id":"2457314642","title":"Liquidia Corporation盘中异动 股价大涨5.06%报11.22美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2457314642","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457314642?lang=zh_cn&edition=full","pubTime":"2024-08-08 21:45","pubTimestamp":1723124729,"startTime":"0","endTime":"0","summary":"北京时间2024年08月08日21时45分，Liquidia Corporation股票出现异动，股价急速拉升5.06%。截至发稿，该股报11.22美元/股，成交量2.4516万股，换手率0.03%，振幅3.18%。Liquidia Corporation股票所在的生物技术行业中，整体涨幅为1.10%。Liquidia Corporation公司简介：Liquidia Corp 是一家总部位于美国的生物制药公司，专注于开发、制造和商业化产品，以满足未满足的患者需求，目前的重点是肺动脉高压  和与间质性肺病相关的肺动脉高压的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240808214529941ff757&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240808214529941ff757&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0211331839.USD","LU1989772923.USD","LU0208291251.USD","LQDA","LU1989772840.SGD","BK4585","BK4161","PH","BK4580","BK4007","LU0070302665.USD","LU0320765489.SGD","BK4588"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.liquidia.com","stockEarnings":[{"period":"1week","weight":-0.0517},{"period":"1month","weight":0.0429},{"period":"3month","weight":-0.0542},{"period":"6month","weight":-0.1632},{"period":"1year","weight":0.5729},{"period":"ytd","weight":-0.1305}],"compareEarnings":[{"period":"1week","weight":-0.019},{"period":"1month","weight":-0.0055},{"period":"3month","weight":0.0913},{"period":"6month","weight":0.1017},{"period":"1year","weight":0.3108},{"period":"ytd","weight":0.1988}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Liquidia Corporation于2020年6月17日在特拉华州成立。该公司是一家生物制药公司，专注于解决未满足患者需求产品的开发、制造和商业化，目前的重点是肺动脉高压的治疗。该公司通过两家全资子公司Liquidia Technologies和Liquidia PAH作为单一实体运营。该公司通过应用心肺疾病方面的专业知识和专有的PRINT技术进行新产品的研究、开发和制造，PRINT技术是一种粒子工程平台，能够精确生产均匀的药物颗粒，旨在提高广泛疗法的安全性、有效性和性能。通过与第三方的产品开发和研究，该公司拥有将PRINT应用于多种给药途径和药物有效载荷的经验，包括吸入疗法、疫苗、生物制剂、核酸和眼科植入物等。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.035484},{"month":2,"riseRate":0.833333,"avgChangeRate":0.087008},{"month":3,"riseRate":0.5,"avgChangeRate":-0.044367},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.075222},{"month":5,"riseRate":0.833333,"avgChangeRate":0.15291},{"month":6,"riseRate":0.166667,"avgChangeRate":-0.059983},{"month":7,"riseRate":0.166667,"avgChangeRate":-0.087113},{"month":8,"riseRate":0.428571,"avgChangeRate":-0.013548},{"month":9,"riseRate":0.428571,"avgChangeRate":0.082402},{"month":10,"riseRate":0.571429,"avgChangeRate":0.019418},{"month":11,"riseRate":0.571429,"avgChangeRate":0.022754},{"month":12,"riseRate":0.666667,"avgChangeRate":0.188565}],"exchange":"NASDAQ","name":"Liquidia Technologies Inc","nameEN":"Liquidia Technologies Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Liquidia Technologies Inc(LQDA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Liquidia Technologies Inc(LQDA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Liquidia Technologies Inc,LQDA,Liquidia Technologies Inc股票,Liquidia Technologies Inc股票老虎,Liquidia Technologies Inc股票老虎国际,Liquidia Technologies Inc行情,Liquidia Technologies Inc股票行情,Liquidia Technologies Inc股价,Liquidia Technologies Inc股市,Liquidia Technologies Inc股票价格,Liquidia Technologies Inc股票交易,Liquidia Technologies Inc股票购买,Liquidia Technologies Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Liquidia Technologies Inc(LQDA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Liquidia Technologies Inc(LQDA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}